10 most popular complementary medicines may interact with cancer therapy
the ONA take:
According to new research presented at the Clinical Oncology Society of Australia's (COSA's) Annual Scientific Meeting in Melbourne, Australia, researchers at Peter MacCallum Cancer Centre in Melbourne have found that the 10 most asked about complementary medicines all may result in drug interactions with administered with chemotherapy, radiation, or prior to surgery.
For the study, researchers identified the 10 most commonly inquired about complementary medicines by providers and patients to the hospital's Medicines Information Centre. Excluding vitamins and minerals, the 10 most commonly asked about complementary medicines were: astragalus, coenzyme Q10, fish oil, ginger, green tea, lactobacillus, licorice, milk thistle, and reishi mushroom.
The researchers note that any of those found in a normal healthy diet would not likely cause adverse effects, but higher quantities consumed in complementary medicines could. These supplemental medicines have the potential to alter the effects of chemotherapy, thereby increasing the patient's risk of toxicity or decreasing the effectiveness of the chemotherapy.
Products that contain high levels of antioxidants can potentially interact with chemotherapy and radiotherapy. Patients should be aware that a natural product may not be safe and a complementary product does not necessarily complement standard cancer therapies.
10 most asked about complementary medicines all may result in drug interactions.
Sign Up for Free e-newsletters
- FDA: Number of U.S. Women With Breast Implant-Caused Cancer Has Increased
- NIH Establishes Educational Program on Genomics, Genetics for Oncology Nurses
- Immunotherapy for HER2-positive Breast Cancer: Recent Advances and Combination Therapeutic Approaches
- A Review of Clinical Outcomes in Patients With Early-Stage Burkitt Lymphoma
- USPSTF Still Recommends Against Pancreatic Cancer Screening
- Oncology Nurse Navigation Facilitates Timely Treatment of Pancreatic Cancer
- Oncology Nurses Weigh In on Their Patient-Centered Communication Practices, Needs
- Substitute for Lidocaine
- CART cell therapy for prostate cancer: status and promise
- Shifting Dynamics of Social Support After a Cancer Diagnosis
- Survey Demonstrates Implicit Bias Toward Cervical Cancer Diagnoses Among Nurses, Women
- Use of Watchful Waiting Up for Low-Risk Localized Prostate Cancer
- Sharing Personal Contact Information With Patients
- Country-Specific Norms Created for Cancer-Related Quality of Life
- Nurse-Led vs Oncologist-Led Breast Cancer Follow-up Program: Early Feasibility Results of an Ongoing Study
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|